Marcello M. Queiroz

Medical Oncologist at Hospital Sírio-Libanês, São Paulo, Brazil

[Denis Jardim @jardim_denis]

Just in 👉Our meta-analysis concerns that neo adjuvant intensified androgen deprivation may be associated with higher incidence of CV and thromboembolic events in prostate cancer. PROTEUS will give definitive information. Pioneering studies from @EfstathiouEleni @DrRanaMcKay

[Marcello M. Queiroz @MQ_Marcello]

Real-world treatment outcomes in HR+ HER2- MBC pts treated w/ cyclin inhibitors (palbo, abema, and ribociclib). Thanks to the whole team at @hsiriolibanes for the work on this paper, the first real-world data of CDK4/6i in the Brazilian population!
https://t.co/WEF01y9QJS

[Marcello M. Queiroz @MQ_Marcello]

Ph2 CA209-9JC: Nivo 1L - treatment-naive aCSCC pts

mFUP 17.6m, mDOR NR
mPFS 12.7m, mOS 20.7m
BORR 58.3% (14/24)
87.5% any grade AES (25% G3/4)
Robust antitumor activity, sustained responses, and good tolerability!

Glad to participate in this incredible work by RR Munhoz!

[ACS Journal Cancer @JournalCancer]

IN THE NEWS | Nivolumab resulted in significant antitumor activity, prolonged responses and a good tolerability in patients with advanced cutaneous squamous-cell carcinoma in the first-line setting. https://t.co/8maGYjdG4I @VivekSubbiah @OncoAlert

[Marcello M. Queiroz @MQ_Marcello]

Glad to publish our recent work in @JCOPO_ASCO ! Thanks to the whole team at @hsiriolibanes for the incredible collaboration on this paper! #immunoonc #PrecisionMedicine @FellowsHsl

[JCO Precision Oncology @JCOPO_ASCO]

#JCOPO case report by @MQ_Marcello et al. of evolutive characterization of genomic and IHC findings in a patient with hepatic sarcomatoid carcinoma and secondary resistance to PD1 blockade: https://t.co/MQAFLgAcpu #gucsm #lcsm #gyncsm

[Marcello M. Queiroz @MQ_Marcello]

Just out! Glad to be part of this publication!

@alineblara
@souza_zenaides
@Felipegaliza
@DiogoAssed

[ecancer @ecancer]

A new report discusses the urgent need to identify predictive biomarkers in order to choose the best treatment for metastatic urothelial carcinoma patients @MQ_Marcello https://t.co/PsdBRiLyr0

[Marcello M. Queiroz @MQ_Marcello]

@FellowsHsl

[Marcello M. Queiroz @MQ_Marcello]

Happy to share our recent case report at EJHI about mismatch between functional imaging and histopathological analysis in PNET. It was an honor to work with @cdiegoholanda, @AleSalgues, @Felipegaliza, Dr. Parenti, Dr. Abe, Dr. Cerqueira and Dra. Capareli
https://t.co/aHPuPxY4Cc

[Leandro Jonata Oliveira @LeandroJonatad1]

Just checked-in at ⁦@myESMO⁩ booth for #ESMO20 with the great ⁦@FellowsHsl⁩ team: ⁦@mauriciofribei1⁩ ⁦@luizagadotti⁩

Tag your friends to take a picture.

I tag: ⁦@BragancaCamilaB⁩ ⁦@alineblara⁩ ⁦@felipescanedo⁩ ⁦@diegoqxda⁩